| Sources | Names Used |
|---|---|
| GDSC1000 | KIN001-260 |
| PharmacoGx | KIN001-260 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ST3GAL2 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | CASP14 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | LCE3E | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | PPP1R1A | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | ALOX5AP | GDSC1000 | pan-cancer | AAC | 0.079 | 0.07 |
| mRNA | TM7SF3 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | SNRNP70 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | ARID5B | GDSC1000 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | BTLA | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | ACTN4 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
